- Report
- April 2023
- 115 Pages
Global
From €4536EUR$4,750USD£3,776GBP
- Report
- April 2023
- 117 Pages
Global
From €4536EUR$4,750USD£3,776GBP
- Report
- January 2022
- 419 Pages
Global
From €9072EUR$9,500USD£7,551GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,140GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,140GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,140GBP
- Report
- January 2023
- 90 Pages
Global
From €3337EUR$3,495USD£2,778GBP
- Report
- March 2020
- 154 Pages
Global
From €10499EUR$10,995USD£8,740GBP
- Report
- August 2022
United States
From €1853EUR$1,940USD£1,542GBP
- Report
- August 2022
Global
From €1041EUR$1,090USD£866GBP
- Report
- May 2023
- 79 Pages
Global
From €3500EUR$3,926USD£3,015GBP
- Report
- May 2023
- 109 Pages
Global
From €3500EUR$3,926USD£3,015GBP
- Report
- August 2022
- 541 Pages
Global
From €2387EUR$2,500USD£1,987GBP
- Report
- July 2022
- 518 Pages
Global
From €1910EUR$2,000USD£1,590GBP
- Report
- December 2023
- 132 Pages
Global
From €907EUR$950USD£755GBP
- Report
- February 2022
- 120 Pages
Global
From €3545EUR$3,712USD£2,951GBP
- Report
- March 2023
- 147 Pages
Global
From €5729EUR$5,999USD£4,768GBP
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more